Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14393)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 26, 2016 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Methodology
ISSN
2222-0682
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gong J, Sachdev E, Mita AC, Mita MM. Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity. World J Methodol 2016; 6(1): 25-42 [PMID: 27019795 DOI: 10.5662/wjm.v6.i1.25] |
|---|---|
| URL: | https://www.wjgnet.com/2222-0682/full/v6/i1/25.htm |
| Number | Citing Articles |
| 1 |
Liang Guo, Jennifer A. Smith, Michelle Abelson, Irina Vlasova-St. Louis, Leslie A. Schiff, Paul R. Bohjanen, Carol J Wilusz. Reovirus infection induces stabilization and up-regulation of cellular transcripts that encode regulators of TGF-β signaling. PLOS ONE 2018; 13(9): e0204622 doi: 10.1371/journal.pone.0204622
|
| 2 |
Chandini M. Thirukkumaran, Zhong Qiao Shi, Gerard J. Nuovo, Joanne Luider, Karen A. Kopciuk, Yuan Dong, Ahmed A. Mostafa, Satbir Thakur, Kathy Gratton, Ailian Yang, Alex C. Chin, Matt C. Coffey, Victor H. Jimenez-Zepeda, Douglas Stewart, Marta Chesi, P. Leif Bergsagel, Don Morris. Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model. Blood Advances 2019; 3(5): 797 doi: 10.1182/bloodadvances.2018025593
|
| 3 |
Adil Mohamed, Qi Feng Lin, Heather E. Eaton, Maya Shmulevitz, Susana López. p38 Mitogen-Activated Protein Kinase Signaling Enhances Reovirus Replication by Facilitating Efficient Virus Entry, Capsid Uncoating, and Postuncoating Steps. Journal of Virology 2023; 97(2) doi: 10.1128/jvi.00009-23
|
| 4 |
Vaishak Kaviarasan, Barath Ragunath, Ramakrishnan Veerabathiran. Oncogenic Viruses. 2023; : 61 doi: 10.1016/B978-0-12-824156-1.00001-7
|
| 5 |
Munazza Fatima, Deeba Amraiz, Muhammad Tariq Navid. Therapeutic Approaches in Cancer Treatment. Cancer Treatment and Research 2023; 185: 105 doi: 10.1007/978-3-031-27156-4_7
|
| 6 |
Jong Kyu Woo, Tae-Geuk Kim, Na Yeon Im, Ka-Yeon Son, Minhyeon Cho, Yeo Jin Jeong, Jeong-Im Hong, BoRim Kang, Gansukh Enkhtaivan, Nam-Hyuk Cho, Tommy Alain, Dong Guk Park, Yeon-Sook Lee. Dual-Armed Oncolytic Myxoma Virus Encoding IFN-γ and CD47 Promotes Lymphocyte Infiltration and Tumor Suppression of Syngeneic Murine Melanoma. Cancers 2023; 15(19): 4703 doi: 10.3390/cancers15194703
|
| 7 |
Paulina Niedźwiedzka-Rystwej, Ewelina Grywalska, Rafał Hrynkiewicz, Mikołaj Wołącewicz, Rafał Becht, Jacek Roliński. The Double-Edged Sword Role of Viruses in Gastric Cancer. Cancers 2020; 12(6): 1680 doi: 10.3390/cancers12061680
|
| 8 |
Naomi Sugimura, Eiji Kubota, Yoshinori Mori, Mineyoshi Aoyama, Mamoru Tanaka, Takaya Shimura, Satoshi Tanida, Randal N. Johnston, Hiromi Kataoka. Reovirus combined with a STING agonist enhances anti-tumor immunity in a mouse model of colorectal cancer. Cancer Immunology, Immunotherapy 2023; 72(11): 3593 doi: 10.1007/s00262-023-03509-0
|
| 9 |
Penelope A. Bradbury, Donald G. Morris, Garth Nicholas, Dongsheng Tu, Moustapha Tehfe, John R. Goffin, Frances A. Shepherd, Richard W. Gregg, Jeffrey Rothenstein, Christoper Lee, Sara Kuruvilla, Bruce D. Keith, Vamsee Torri, Normand Blais, Desiree Hao, Grzegorz J. Korpanty, Glenwood Goss, Barbara L. Melosky, Mihaela Mates, Natasha Leighl, Jean-Pierre Ayoub, Joana Sederias, Harriet Feilotter, Lesley Seymour, Scott A. Laurie. Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy. Lung Cancer 2018; 120: 142 doi: 10.1016/j.lungcan.2018.03.005
|
| 10 |
Simone Hager, Frederic Julien Fittler, Ernst Wagner, Matthias Bros. Nucleic Acid-Based Approaches for Tumor Therapy. Cells 2020; 9(9): 2061 doi: 10.3390/cells9092061
|
| 11 |
P. Chalan, G. Di Dalmazi, F. Pani, A. De Remigis, A. Corsello, P. Caturegli. Thyroid dysfunctions secondary to cancer immunotherapy. Journal of Endocrinological Investigation 2018; 41(6): 625 doi: 10.1007/s40618-017-0778-8
|
| 12 |
Antonela S. Asad, Mariela A. Moreno Ayala, M. Florencia Gottardo, Camila Zuccato, Alejandro Javier Nicola Candia, Flavia A. Zanetti, Adriana Seilicovich, Marianela Candolfi. Viral gene therapy for breast cancer: progress and challenges. Expert Opinion on Biological Therapy 2017; 17(8): 945 doi: 10.1080/14712598.2017.1338684
|
| 13 |
Sun-Il Kwon. The Trend in the Development of Oncolytic Virus Therapy. Biomedical Science Letters 2019; 25(3): 201 doi: 10.15616/BSL.2019.25.3.201
|
| 14 |
Louise Müller, Robert Berkeley, Tyler Barr, Elizabeth Ilett, Fiona Errington-Mais. Past, Present and Future of Oncolytic Reovirus. Cancers 2020; 12(11): 3219 doi: 10.3390/cancers12113219
|
| 15 |
E.D. Ledgerwood. Reference Module in Biomedical Sciences. 2019; doi: 10.1016/B978-0-12-801238-3.02651-9
|
| 16 |
Christopher J. LaRocca, Susanne G. Warner. Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials. Clinical and Translational Medicine 2018; 7(1) doi: 10.1186/s40169-018-0214-5
|
| 17 |
Katsuhiro Ogawa, Kentaro Yamada, Tsuyoshi Etoh, Masahiro Kitagawa, Yoshinori Shirasaka, Kazuko Noguchi, Takeshi Kobayashi, Akira Nishizono, Masafumi Inomata. Development of an oncolytic mammalian orthoreovirus expressing the near-infrared fluorescent protein iRFP720. Journal of Virological Methods 2022; 308: 114574 doi: 10.1016/j.jviromet.2022.114574
|
| 18 |
Daniel E. Meyers, Satbir Thakur, Chandini M. Thirukkumaran, Don G. Morris. Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma. Blood Cancer Journal 2017; 7(12) doi: 10.1038/s41408-017-0020-0
|
| 19 |
Ulrich M Lauer, Julia Beil. Oncolytic viruses: challenges and considerations in an evolving clinical landscape. Future Oncology 2022; 18(24): 2713 doi: 10.2217/fon-2022-0440
|
| 20 |
David E. Cohn, Michael W. Sill, Joan L. Walker, David O'Malley, Christa I. Nagel, Teresa L. Rutledge, William Bradley, Debra L. Richardson, Katherine M. Moxley, Carol Aghajanian. Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology 2017; 146(3): 477 doi: 10.1016/j.ygyno.2017.07.135
|
| 21 |
Vera Kemp, Iris J. C. Dautzenberg, Steve J. Cramer, Rob C. Hoeben, Diana J. M. van den Wollenberg. Characterization of a replicating expanded tropism oncolytic reovirus carrying the adenovirus E4orf4 gene. Gene Therapy 2018; 25(5): 331 doi: 10.1038/s41434-018-0032-9
|
| 22 |
Tarryn Bourhill, Yoshinori Mori, Derrick Rancourt, Maya Shmulevitz, Randal Johnston. Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection. Viruses 2018; 10(8): 421 doi: 10.3390/v10080421
|
| 23 |
Jolien De Munck, Alex Binks, Iain A McNeish, Joeri L Aerts. Oncolytic virus-induced cell death and immunity: a match made in heaven?. Journal of Leukocyte Biology 2017; 102(3): 631 doi: 10.1189/jlb.5RU0117-040R
|
| 24 |
Michael A. Giacomantonio, Andra M. Sterea, Youra Kim, Joao A. Paulo, Derek R. Clements, Barry E. Kennedy, Moamen J. Bydoun, Ge Shi, David M. Waisman, Steven P. Gygi, Carman A. Giacomantonio, J. Patrick Murphy, Shashi Gujar. Quantitative Proteome Responses to Oncolytic Reovirus in GM-CSF- and M-CSF-Differentiated Bone Marrow-Derived Cells. Journal of Proteome Research 2020; 19(2): 708 doi: 10.1021/acs.jproteome.9b00583
|
| 25 |
Qiaoshuai Lan, Shuai Xia, Qian Wang, Wei Xu, Haiyan Huang, Shibo Jiang, Lu Lu. Development of oncolytic virotherapy: from genetic modification to combination therapy. Frontiers of Medicine 2020; 14(2): 160 doi: 10.1007/s11684-020-0750-4
|
| 26 |
Sushil Kumar Sahu, Mukesh Kumar. Microbial Biotechnology. 2018; : 361 doi: 10.1007/978-981-10-7140-9_17
|
| 27 |
Giti Esmail Nia, Elahe Nikpayam, Molood Farrokhi, Azam Bolhassani, Ralph Meuwissen. Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer. Molecular Therapy: Oncology 2024; 32(1): 200788 doi: 10.1016/j.omton.2024.200788
|
| 28 |
Charles Comins, Guy Richard Simpson, William Rogers, Kate Relph, Kevin Harrington, Alan Melcher, Victoria Roulstone, Joan Kyula, Hardev Pandha. Synergistic antitumour effects of rapamycin and oncolytic reovirus. Cancer Gene Therapy 2018; 25(5-6): 148 doi: 10.1038/s41417-018-0011-8
|
| 29 |
Stanley Du Preez, Farhadul Islam, Tracie Cheng. Cancer Stem Cells: Basic Concept and Therapeutic Implications. 2023; : 237 doi: 10.1007/978-981-99-3185-9_13
|
| 30 |
Lingwan Xie, Yinze Han, Yuanzhi Liu, Yanmei Zhou, Jiao Yu, Albrecht von Brunn, Jian Lei. Viral vector‐based cancer treatment and current clinical applications. MedComm – Oncology 2023; 2(4) doi: 10.1002/mog2.55
|
| 31 |
Muhammad Farhan Siddiq Rao, Bilal Ahmed, Muhammad Imran Qadir.
Oncolytic Virotherapy: An Advanced Microbial Approach for the Management of Cancer
. Critical Reviews in Eukaryotic Gene Expression 2024; 34(1): 1 doi: 10.1615/CritRevEukaryotGeneExpr.2023048962
|
| 32 |
Chaolong Lin, Wenzhong Teng, Yang Tian, Shaopeng Li, Ningshao Xia, Chenghao Huang. Immune landscape and response to oncolytic virus-based immunotherapy. Frontiers of Medicine 2024; 18(3): 411 doi: 10.1007/s11684-023-1048-0
|
| 33 |
Anwen Howells, Giulia Marelli, Nicholas R. Lemoine, Yaohe Wang. Oncolytic Viruses—Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer. Frontiers in Oncology 2017; 7 doi: 10.3389/fonc.2017.00195
|
| 34 |
Peter Jianrui Liu, Peter Balfe, Jane A McKeating, Mirjam Schilling. Oxygen Sensing and Viral Replication: Implications for Tropism and Pathogenesis. Viruses 2020; 12(11): 1213 doi: 10.3390/v12111213
|
| 35 |
Tarryn Bourhill, Leili Rohani, Mehul Kumar, Pinaki Bose, Derrick Rancourt, Randal N. Johnston. Modulation of Reoviral Cytolysis (II): Cellular Stemness. Viruses 2023; 15(7): 1473 doi: 10.3390/v15071473
|
| 36 |
Renxian Xie, Hongxin Huang, Tong Chen, Xuehan Huang, Chuangzhen Chen. Effectiveness and safety of pelareorep plus chemotherapy versus chemotherapy alone for advanced solid tumors: a meta-analysis. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1228225
|
| 37 |
Ayesha Tariq, Helen Piontkivska. Reovirus infection induces transcriptome-wide unique A-to-I editing changes in the murine fibroblasts.. Virus Research 2024; 346: 199413 doi: 10.1016/j.virusres.2024.199413
|
| 38 |
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, Summya Rashid, Muhammad Omer Iqbal, Renata Kontek, Muhanad A. Abdulsamad, Abdulmutalib A. Allaq. Recent Advances in Molecular Mechanisms of Cancer Immunotherapy. Cancers 2023; 15(10): 2721 doi: 10.3390/cancers15102721
|
| 39 |
Kanaka Dhuri, Sankalp Gharat, Nikita Fernandes, Vivek Basudkar, Gaurav Doshi, Munira Momin. Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives. Journal of Drug Delivery Science and Technology 2024; 92: 105365 doi: 10.1016/j.jddst.2024.105365
|
| 40 |
Janaina Fernandes. Oncogenes: The Passport for Viral Oncolysis through PKR Inhibition. Biomarkers in Cancer 2016; 8: BIC.S33378 doi: 10.4137/BIC.S33378
|
| 41 |
Katherine Cook, Lindy Durrant, Victoria Brentville. Current Strategies to Enhance Anti-Tumour Immunity. Biomedicines 2018; 6(2): 37 doi: 10.3390/biomedicines6020037
|
| 42 |
Henglong Hu, Qidong Xia, Jia Hu, Shaogang Wang. Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects. Journal of Clinical Medicine 2022; 11(23): 6997 doi: 10.3390/jcm11236997
|
| 43 |
Wenqing Ma, Hongbin He, Hongmei Wang. Oncolytic herpes simplex virus and immunotherapy. BMC Immunology 2018; 19(1) doi: 10.1186/s12865-018-0281-9
|
| 44 |
Yan Zhang, Xinyu Shi, Yifan Shen, Xiulin Dong, Ruiqing He, Guo Chen, Yan Zhang, Honghong Tan, Kun Zhang. Nanoengineering‐armed oncolytic viruses drive antitumor response: progress and challenges. MedComm 2024; 5(10) doi: 10.1002/mco2.755
|
| 45 |
Yoshiaki Yura, Masakazu Hamada. Development of oncolytic virotherapy for the treatment of oral cancer – At the waiting stage for clinical use. Oral Science International 2017; 14(1): 1 doi: 10.1016/S1348-8643(16)30016-7
|
| 46 |
Kathleen K. M. Glover, Danica M. Sutherland, Terence S. Dermody, Kevin M. Coombs. A Single Point Mutation, Asn16→Lys, Dictates the Temperature-Sensitivity of the Reovirus tsG453 Mutant. Viruses 2021; 13(2): 289 doi: 10.3390/v13020289
|
| 47 |
Matthew Chiu, Edward John Lloyd Armstrong, Vicki Jennings, Shane Foo, Eva Crespo-Rodriguez, Galabina Bozhanova, Emmanuel Christian Patin, Martin McLaughlin, David Mansfield, Gabriella Baker, Lorna Grove, Malin Pedersen, Joan Kyula, Victoria Roulstone, Anna Wilkins, Fiona McDonald, Kevin Harrington, Alan Melcher. Combination therapy with oncolytic viruses and immune checkpoint inhibitors. Expert Opinion on Biological Therapy 2020; 20(6): 635 doi: 10.1080/14712598.2020.1729351
|
| 48 |
Carly DeAntoneo, Pranav Danthi, Siddharth Balachandran. Reovirus Activated Cell Death Pathways. Cells 2022; 11(11): 1757 doi: 10.3390/cells11111757
|
| 49 |
Tanvir Ahmed. Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme. MedComm – Oncology 2023; 2(1) doi: 10.1002/mog2.23
|
| 50 |
Takahiro Kawagishi, Yuta Kanai, Ryotaro Nouda, Ichika Fukui, Jeffery A. Nurdin, Yoshiharu Matsuura, Takeshi Kobayashi, Susana López. Generation of Genetically RGD σ1-Modified Oncolytic Reovirus That Enhances JAM-A-Independent Infection of Tumor Cells. Journal of Virology 2020; 94(23) doi: 10.1128/JVI.01703-20
|
| 51 |
Hiroshi Fukuhara, Yasushi Ino, Tomoki Todo. Oncolytic virus therapy: A new era of cancer treatment at dawn. Cancer Science 2016; 107(10): 1373 doi: 10.1111/cas.13027
|
| 52 |
Alexandra Doms, Tatiana Sanabria, Jeanne N. Hansen, Nihal Altan-Bonnet, Geoffrey H. Holm, Susana López. 25-Hydroxycholesterol Production by the Cholesterol-25-Hydroxylase Interferon-Stimulated Gene Restricts Mammalian Reovirus Infection. Journal of Virology 2018; 92(18) doi: 10.1128/JVI.01047-18
|
| 53 |
Andrew M. Gardeck, Jordan Sheehan, Walter C. Low. Immune and viral therapies for malignant primary brain tumors. Expert Opinion on Biological Therapy 2017; 17(4): 457 doi: 10.1080/14712598.2017.1296132
|
| 54 |
Ilse Hernandez-Aguirre, Kevin A. Cassady. Cancer Immunology and Immunotherapy. 2022; : 375 doi: 10.1016/B978-0-12-823397-9.00012-0
|
| 55 |
Satoru Taguchi, Hiroshi Fukuhara, Tomoki Todo. Oncolytic virus therapy in Japan: progress in clinical trials and future perspectives. Japanese Journal of Clinical Oncology 2019; 49(3): 201 doi: 10.1093/jjco/hyy170
|
| 56 |
Kyle M. Pierce, William R. Miklavcic, Kyle P. Cook, Mikayla Sweitzer Hennen, Kenneth W. Bayles, Michael A. Hollingsworth, Amanda E. Brooks, Jessica E. Pullan, Kaitlin M. Dailey. The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors. Nanomaterials 2021; 11(11): 3018 doi: 10.3390/nano11113018
|
| 57 |
Danni Lin, Yinan Shen, Tingbo Liang. Oncolytic virotherapy: basic principles, recent advances and future directions. Signal Transduction and Targeted Therapy 2023; 8(1) doi: 10.1038/s41392-023-01407-6
|
| 58 |
Seyed-Mahmood Seyed-Khorrami, Hoorieh Soleimanjahi, Sara Soudi, Ala Habibian. MSCs loaded with oncolytic reovirus: migration and in vivo virus delivery potential for evaluating anti-cancer effect in tumor-bearing C57BL/6 mice. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01848-5
|
| 59 |
Iris J. C. Dautzenberg, Sanne K. van den Hengel, Jeroen de Vrij, Lars Ravesloot, Steve J. Cramer, Saw-See Hong, Diana J. M. van den Wollenberg, Pierre Boulanger, Rob C. Hoeben. Baculovirus-assisted Reovirus Infection in Monolayer and Spheroid Cultures of Glioma cells. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-17709-z
|
| 60 |
Luke D. Bussiere, Cathy L. Miller. Inhibition of HIF-1α accumulation in prostate cancer cells is initiated during early stages of mammalian orthoreovirus infection. Virology 2021; 558: 38 doi: 10.1016/j.virol.2021.02.014
|
| 61 |
Razieh S. Banijamali, Hoorieh Soleimanjahi, Sara Soudi, Hesam Karimi. Mesenchymal stem cells support delivery and boost the efficacy of oncolytic reoviruses in TC‐1 tumor cells. Journal of Cellular Biochemistry 2021; 122(10): 1360 doi: 10.1002/jcb.29955
|
| 62 |
Joana N. R. Dias, Ana S. André, Sandra I. Aguiar, Solange Gil, Luís Tavares, Frederico Aires-da-Silva. Immunotherapeutic Strategies for Canine Lymphoma: Changing the Odds Against Non-Hodgkin Lymphoma. Frontiers in Veterinary Science 2021; 8 doi: 10.3389/fvets.2021.621758
|
| 63 |
Seyed-Mahmood Seyed-Khorrami, Hoorieh Soleimanjahi, Marek J. Łos, Keivan Zandi, Reza Zolfaghari Emameh. Oncolytic viruses as emerging therapy against cancers including Oncovirus-induced cancers. European Journal of Pharmacology 2023; 939: 175393 doi: 10.1016/j.ejphar.2022.175393
|
| 64 |
Bernhard Josef Eigl, Kim Chi, Dongsheng Tu, Sebastien J. Hotte, Eric Winquist, Christopher M. Booth, Christina Canil, Kylea Potvin, Richard Gregg, Scott North, Muhammad Zulfiqar, Susan Ellard, Joseph Dean Ruether, Lyly Le, A. Saranya Kakumanu, Mohammad Salim, Alison L. Allan, Harriet Feilotter, Ashley Theis, Lesley Seymour. A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209. Oncotarget 2018; 9(8): 8155 doi: 10.18632/oncotarget.24263
|
| 65 |
Dörthe Masemann, Yvonne Boergeling, Stephan Ludwig. Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapy. Biological Chemistry 2017; 398(8): 891 doi: 10.1515/hsz-2017-0103
|
| 66 |
Sanjay Goel, Allyson J. Ocean, Ruwan Y. Parakrama, Mohammad H. Ghalib, Imran Chaudhary, Umang Shah, Sengottuvel Viswanathan, Himanshu Kharkwal, Matthew Coffey, Radhashree Maitra. Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with KRAS-Mutated Colorectal Cancer. Molecular Cancer Therapeutics 2020; 19(5): 1148 doi: 10.1158/1535-7163.MCT-19-1117
|
| 67 |
|
| 68 |
June Kyu Hwang, JinWoo Hong, Chae-Ok Yun. Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials. International Journal of Molecular Sciences 2020; 21(22): 8627 doi: 10.3390/ijms21228627
|
| 69 |
Zhan Wang, Peng Sun, Zhiyong Li, Shaowen Xiao. Clinical Advances and Future Directions of Oncolytic Virotherapy for Head and Neck Cancer. Cancers 2023; 15(21): 5291 doi: 10.3390/cancers15215291
|
| 70 |
Parvaneh Mehrbod, Sudharsana R. Ande, Javad Alizadeh, Shahrzad Rahimizadeh, Aryana Shariati, Hadis Malek, Mohammad Hashemi, Kathleen K. M. Glover, Affan A. Sher, Kevin M. Coombs, Saeid Ghavami. The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections. Virulence 2019; 10(1): 376 doi: 10.1080/21505594.2019.1605803
|
| 71 |
Luke D. Bussiere, Cathy L. Miller. Reovirus and the Host Integrated Stress Response: On the Frontlines of the Battle to Survive. Viruses 2021; 13(2): 200 doi: 10.3390/v13020200
|
| 72 |
Tashmeen Kaur, Deepika Sharma. . Advances in Applied Microbiology 2023; 123: 91 doi: 10.1016/bs.aambs.2023.03.001
|
| 73 |
Mary Frances Wedekind, Timothy P. Cripe. Current Advances in the Science of Osteosarcoma. Advances in Experimental Medicine and Biology 2020; 1258: 77 doi: 10.1007/978-3-030-43085-6_5
|
| 74 |
Yusuke Inagaki, Eiji Kubota, Yoshinori Mori, Mineyoshi Aoyama, Hiromi Kataoka, Randal N. Johnston, Takashi Joh. Anti-tumor efficacy of oncolytic reovirus against gastrointestinal stromal tumor cells. Oncotarget 2017; 8(70): 115632 doi: 10.18632/oncotarget.23361
|
| 75 |
Noraini Abd-Aziz, Chit Laa Poh. Development of oncolytic viruses for cancer therapy. Translational Research 2021; 237: 98 doi: 10.1016/j.trsl.2021.04.008
|
| 76 |
Mingjing Deng, Qi Wang. Research Advances of Clinical Application of Oncolytic Viruses in Treatment
of Gynecologic Cancers. Current Cancer Drug Targets 2023; 23(7): 505 doi: 10.2174/1568009623666230221154415
|
| 77 |
Mitchell E. Menezes, Sarmistha Talukdar, Stephen L. Wechman, Swadesh K. Das, Luni Emdad, Devanand Sarkar, Paul B. Fisher. . Advances in Cancer Research 2018; 138: 213 doi: 10.1016/bs.acr.2018.02.007
|
| 78 |
Amirhossein Bahreyni, Elnaz Ghorbani, Hamid Fuji, Mikhail Ryzhikov, Majid Khazaei, Marjan Erfani, Amir Avan, Seyed M. Hassanian, Kayhan Azadmanesh. Therapeutic potency of oncolytic virotherapy–induced cancer stem cells targeting in brain tumors, current status, and perspectives. Journal of Cellular Biochemistry 2019; 120(3): 2766 doi: 10.1002/jcb.27661
|
| 79 |
Matthew R Schuelke, Justin H Gundelach, Matt Coffey, Emma West, Karen Scott, Derek R Johnson, Adel Samson, Alan Melcher, Richard G Vile, Richard J Bram. Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors. Neuro-Oncology Advances 2022; 4(1) doi: 10.1093/noajnl/vdac085
|
| 80 |
Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos, Marcel Silva Luz, João Victor Silva Souza, Samuel Luca Rocha Pinheiro, Wedja Rafaela de Souza, Matheus Sande Loureiro, Fabrício Freire de Melo. Oncolytic virus therapy in cancer: A current review. World Journal of Virology 2021; 10(5): 229-255 doi: 10.5501/wjv.v10.i5.229
|
| 81 |
Syed Umar Faruq Syed Najmuddin, Zahiah Mohamed Amin, Sheau Wei Tan, Swee Keong Yeap, Jeevanathan Kalyanasundram, Abhimanyu Veerakumarasivam, Soon Choy Chan, Suet Lin Chia, Khatijah Yusoff, Noorjahan Banu Alitheen. Oncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxn1nu nude mice. PeerJ 2020; 8: e9761 doi: 10.7717/peerj.9761
|
| 82 |
Wan Kong (Wynton) Yip, Francisca Cristi, Georgi Trifonov, Nashae Narayan, Mark Kubanski, Maya Shmulevitz, Rebecca Ellis. Dutch. The Reovirus μ2 C-Terminal Loop Inversely Regulates NTPase and Transcription Functions versus Binding to Factory-Forming μNS and Promotes Replication in Tumorigenic Cells. Journal of Virology 2021; 95(10) doi: 10.1128/JVI.02006-20
|
| 83 |
Arwa Abdulla Baabdulla, Thomas Hillen. Oscillations in a Spatial Oncolytic Virus Model. Bulletin of Mathematical Biology 2024; 86(8) doi: 10.1007/s11538-024-01322-z
|
| 84 |
Diana Sánchez, Gabriela Cesarman-Maus, Alfredo Amador-Molina, Marcela Lizano. Oncolytic Viruses for Canine Cancer Treatment. Cancers 2018; 10(11): 404 doi: 10.3390/cancers10110404
|
| 85 |
Justin Maroun, Miguel Muñoz-Alía, Arun Ammayappan, Autumn Schulze, Kah-Whye Peng, Stephen Russell. Designing and Building Oncolytic Viruses. Future Virology 2017; 12(4): 193 doi: 10.2217/fvl-2016-0129
|
| 86 |
Thomas Karadimas, Thien Huong Huynh, Chloe Chose, Guston Zervoudakis, Bryan Clampitt, Sean Lapp, David Joyce, George Douglas Letson, Jonathan Metts, Odion Binitie, John E. Mullinax, Alexander Lazarides. Oncolytic Viral Therapy in Osteosarcoma. Viruses 2024; 16(7): 1139 doi: 10.3390/v16071139
|
| 87 |
Ana Laura Alfano, Alejandro Nicola Candia, Nicasio Cuneo, Leandro N. Guttlein, Alejandro Soderini, Cecilia Rotondaro, Leonardo Sganga, Osvaldo L. Podhajcer, M. Veronica Lopez. Oncolytic Adenovirus-Loaded Menstrual Blood Stem Cells Overcome the Blockade of Viral Activity Exerted by Ovarian Cancer Ascites. Molecular Therapy - Oncolytics 2017; 6: 31 doi: 10.1016/j.omto.2017.06.002
|
| 88 |
Aleksandra Sikora, Kevin M. Sullivan, Sean Dineen, Mustafa Raoof, Aleksandra Karolak. Emerging therapeutic approaches for peritoneal metastases from gastrointestinal cancers. Molecular Therapy: Oncology 2024; 32(1): 200767 doi: 10.1016/j.omton.2024.200767
|
| 89 |
Mohamed Abdelmoneim, Ibrahim Ragab Eissa, Mona Alhussein Aboalela, Yoshinori Naoe, Shigeru Matsumura, Patricia Angela Sibal, Itzel Bustos-Villalobos, Maki Tanaka, Yasuhiro Kodera, Hideki Kasuya. Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-25065-w
|
| 90 |
Monika A. Papież, Wirginia Krzyściak. Biological Therapies in the Treatment of Cancer—Update and New Directions. International Journal of Molecular Sciences 2021; 22(21): 11694 doi: 10.3390/ijms222111694
|
| 91 |
Mahalaxmi Iyer, Nandita Ravichandran, Panimalar Abirami Karuppusamy, Roselin Gnanarajan, Mukesh Kumar Yadav, Arul Narayanasamy, Balachandar Vellingiri. Immunology for Engineers. Advances in Protein Chemistry and Structural Biology 2024; 140: 419 doi: 10.1016/bs.apcsb.2023.12.007
|
| 92 |
Li Yang, Aitian Li, Ying Wang, Yi Zhang. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduction and Targeted Therapy 2023; 8(1) doi: 10.1038/s41392-022-01304-4
|
| 93 |
Junjie Chen, Kailang Chen, Xianglin Yuan. Advances in the therapeutic study of oncolytic virus in colorectal cancer. Oncology and Translational Medicine 2024; 10(4): 171 doi: 10.1097/ot9.0000000000000051
|
| 94 |
Chigozirim N. Ekeke, Kira L. Russell, Kyla Joubert, David L. Bartlett, James D. Luketich, Adam C. Soloff, Zong Sheng Guo, Michael T. Lotze, Rajeev Dhupar. Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies. Annals of Surgical Oncology 2021; 28(5): 2715 doi: 10.1245/s10434-020-09477-4
|
| 95 |
Antonia Reyes, Luisa F. Duarte, Mónica A. Farías, Eduardo Tognarelli, Alexis M. Kalergis, Susan M. Bueno, Pablo A. González. Impact of Hypoxia over Human Viral Infections and Key Cellular Processes. International Journal of Molecular Sciences 2021; 22(15): 7954 doi: 10.3390/ijms22157954
|
| 96 |
Vera Kemp, Martine L.M. Lamfers, Gabri van der Pluijm, Bernadette G. van den Hoogen, Rob C. Hoeben. Developing oncolytic viruses for clinical use: A consortium approach. Cytokine & Growth Factor Reviews 2020; 56: 133 doi: 10.1016/j.cytogfr.2020.06.010
|